Bioresorbable drug eluting scaffolds-are bioresorbable stents ready for today's clinical practice?

about

Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome.

P2860

Q39316987-E8BED4D3-4839-463D-9444-7687E9955AEC

P2860

Bioresorbable drug eluting scaffolds-are bioresorbable stents ready for today's clinical practice?

Item

http://www.wikidata.org/entity/Q42751286

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bioresorbable drug eluting sca ...... for today's clinical practice?

@en

Bioresorbable drug eluting sca ...... for today's clinical practice?

@nl

type

Item

label

Bioresorbable drug eluting sca ...... for today's clinical practice?

@en

Bioresorbable drug eluting sca ...... for today's clinical practice?

@nl

prefLabel

Bioresorbable drug eluting sca ...... for today's clinical practice?

@en

Bioresorbable drug eluting sca ...... for today's clinical practice?

@nl

P1476

Bioresorbable drug eluting sca ...... for today's clinical practice?

@en

P2093

Christoph Lutter

http://www.w3.org/2001/XMLSchema#string

Michael Joner

http://www.w3.org/2001/XMLSchema#string

P2860

Bioresorbable scaffolds: rationale, current status, challenges, and future.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a cli

Tools & techniques--statistics: propensity score techniques.

Permanent and biodegradable polymer coatings in the absence of antiproliferative drugs in a porcine model of coronary artery stenting.

P304

1050-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2016.04.28

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27293816

http://www.w3.org/2001/XMLSchema#string

P932

4886008

http://www.w3.org/2001/XMLSchema#string

Bioresorbable drug eluting scaffolds-are bioresorbable stents ready for today's clinical practice?

about

P2860

P2860

Bioresorbable drug eluting scaffolds-are bioresorbable stents ready for today's clinical practice?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932